Quantitative changes in interleukin proteins following focal stroke in the rat

被引:94
作者
Legos, JJ
Whitmore, RG
Erhardt, JA
Parsons, AA
Tuma, RF
Barone, FC
机构
[1] SmithKline Beecham Pharmaceut, Dept Cardiovasc Pharmacol, King Of Prussia, PA 19406 USA
[2] Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19122 USA
关键词
focal cerebral ischemia; cytokines; interleukin-1; interleukin-1 receptor antagonist; interleukin-6; rats;
D O I
10.1016/S0304-3940(00)00907-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aim of the present study was to quantitate the temporal changes in protein concentration for interleukin (IL)-1, IL-1 beta, IL-1ra, and IL-6 from 1 h to 15 days following focal ischemia. Protein expression was evaluated by enzyme-linked immunosorbent assay utilizing newly available rat antibodies. There were no detectable basal levels of IL-1 alpha, 1L-1 beta, or IL-6 in the sham-operated or non-ischemic control cortex. IL-1 beta (increased significantly (P < 0.05) as early as 4 h and peaked at 3 to 5 days. IL-1 alpha (increased significantly (P < 0.05) at 3 days. IL-6 increased early and peaked at 24 h (P < 0.05). IL-1ra increased significantly (P < 0.05) over basal levels from 12 h to 5 days. The present study provides the first quantitative determination of interleukin protein concentrations in the rat brain following focal stroke and demonstrates that this technology is now available for mechanistic studies in neuroprotection. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:189 / 192
页数:4
相关论文
共 20 条
[1]   INTERLEUKIN-6 IN BIOLOGY AND MEDICINE [J].
AKIRA, S ;
TAGA, T ;
KISHIMOTO, T .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :1-78
[2]   GENETIC-HYPERTENSION AND INCREASED SUSCEPTIBILITY TO CEREBRAL-ISCHEMIA [J].
BARONE, FC ;
PRICE, WJ ;
WHITE, RF ;
WILLETTE, RN ;
FEUERSTEIN, GZ .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1992, 16 (02) :219-233
[3]   Ischemic preconditioning and brain tolerance - Temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression [J].
Barone, FC ;
White, RF ;
Spera, PA ;
Ellison, J ;
Currie, RW ;
Wang, XK ;
Feuerstein, GZ .
STROKE, 1998, 29 (09) :1937-1950
[4]   INTERLEUKIN-6 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN ACUTE STROKE [J].
BEAMER, NB ;
COULL, BM ;
CLARK, WM ;
HAZEL, JS ;
SILBERGER, JR .
ANNALS OF NEUROLOGY, 1995, 37 (06) :800-805
[5]   INDUCTION OF INTERLEUKIN-1-BETA MESSENGER-RNA AFTER FOCAL CEREBRAL-ISCHEMIA IN THE RAT [J].
BUTTINI, M ;
SAUTER, A ;
BODDEKE, HWGM .
MOLECULAR BRAIN RESEARCH, 1994, 23 (1-2) :126-134
[6]   Time course of IL-6 expression in experimental CNS ischemia [J].
Clark, WM ;
Rinker, LG ;
Lessov, NS ;
Hazel, K ;
Eckenstein, F .
NEUROLOGICAL RESEARCH, 1999, 21 (03) :287-292
[7]  
DINARELLO CA, 1992, CHEM IMMUNOL, V51, P1
[8]   The role of cytokines in the neuropathology of stroke and neurotrauma [J].
Feuerstein, GZ ;
Wang, XK ;
Barone, FC .
NEUROIMMUNOMODULATION, 1998, 5 (3-4) :143-159
[9]   INTERLEUKIN-1-BETA MESSENGER-RNA EXPRESSION IN ISCHEMIC RAT CORTEX [J].
LIU, T ;
MCDONNELL, PC ;
YOUNG, PR ;
WHITE, RF ;
SIREN, AL ;
HALLENBECK, JM ;
BARONE, FC ;
FEURERSTEIN, GZ .
STROKE, 1993, 24 (11) :1746-1751
[10]   Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat [J].
Loddick, SA ;
Turnbull, AV ;
Rothwell, NJ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (02) :176-179